Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 22 nd Annual Global Healthcare Conference on Wednesday, September 4 th , held at the New York Marriott Marquis, New York, NY. Joaquin Duato, Chairman and Chief Executive Officer and John Reed, Executive Vice President, Innovative Medicine, R&D will represent the Company in a session scheduled at 10:45 am (Eastern Time).
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
The audio webcast replay will be available approximately 48-hrs after the webcast.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240723451320/en/
Media contact:
media-relations@its.jnj.com
Investor contact:
investor-relations@its.jnj.com